Cargando…
Safety evaluation of the interchangeable use of robenacoxib in commercially-available tablets and solution for injection in cats
BACKGROUND: Robenacoxib (Onsior™) is a non-steroidal anti-inflammatory drug developed for canine and feline use for the control of pain and inflammation. It is available as both tablets and solution for injection. The objective of this study was to evaluate the safety of the interchangeable use of c...
Autores principales: | Heit, Mark C., Stallons, L. Jay, Seewald, Wolfgang, Thompson, Caryn M, Toutain, Céline E., King, Stephen B., Helbig, Rainer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520961/ https://www.ncbi.nlm.nih.gov/pubmed/32988403 http://dx.doi.org/10.1186/s12917-020-02553-7 |
Ejemplares similares
-
Safety evaluation of the interchangeable use of robenacoxib (Onsior™) tablets and solution for injection in dogs
por: Toutain, Céline E., et al.
Publicado: (2017) -
Six-month safety evaluation of robenacoxib tablets (Onsior™) in dogs after daily oral administrations
por: Toutain, Céline E., et al.
Publicado: (2018) -
Clinical safety of robenacoxib in cats with chronic musculoskeletal disease
por: King, Jonathan N., et al.
Publicado: (2021) -
Effect of benazepril, robenacoxib and their combination on glomerular filtration rate in cats
por: King, Jonathan N., et al.
Publicado: (2016) -
Efficacy and safety of oral robenacoxib (tablet) for the treatment of pain associated with soft tissue surgery in client-owned dogs
por: Friton, Gabriele, et al.
Publicado: (2017)